Skip to main content
SpringerLink
Log in

The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

The role of Epstein-Barr virus (EBV) in the pathogenesis of Hodgkin's disease (HD) has not yet been clarified. Using RNA in situ hybridization (ISH) and immunohistochemistry (IHC), the occurrence of small Epstein-Barr virus encoded RNA (EBER) and latent membrane protein-1 (LMP-1) was studied in 22 tissue samples from 21 patients between 4 and 17 years of age with Hodgkin's disease. EBER was detected in eight of 21 patients (38%) in Hodgkin and Reed-Sternberg cells and reactive lymphocytes irrespective of initial clinical stage and histological subtype, whereas LMP-1, positive in ten of 21 patients (48%), was restricted to neoplastic cells. All cases positive for EBER expressed LMP-1 as well. Additionally, oncoprotein Bcl-2 was identified in nine of 21 patients (43%), indicating, besides immortalization of HD cells by EBV, a further growth advantage due to apoptosis prevention by overexpression of this protein. Proliferation-associated antigens Ki-S1 and Ki-S5 were highly expressed in Hodgkin and Reed-Sternberg cells. CD 30 antigen was found in most cases, using two different antibodies (90% and 80%). The presence of this protein, which belongs to the family of nerve growth factor receptor (NGFR), is related to high expression of Ki-67 protein, detected by Ki-S5. CD 20 antigen was detectable in only three of 21 patients (14%). If we compare results of ISH and IHC with clinical data, the occurrence of EBV genome in children with HD seems to have no adverse effect on the final outcome of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aisenberg AC (1991) Malignant lymphoma. Biology, natural history and treatment. Lea & Febiger, Philadelphia

    Google Scholar 

  2. Ambinder RF, Browning PJ, Lorenzana I, Leventhal BG, Cosenza H, Mann RB, MacMahon EME, Medina R, Cordona V, Grufferman S, Olshan A, Levin A, Petersen EA, Blattner W, Levine PH (1993) Epstein-Barr virus and childhood Hodgkin's disease in Honduras and United States. Blood 81:462–467

    Google Scholar 

  3. Anagnostopoulos I, Herbst H, Niedobitek G, Stein H (1989) Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphomas by combined Southern blot and in situ hybridization. Blood 74:810–816

    Google Scholar 

  4. Bissonette RP, Echeverri F, Mahboubi A, Green DR (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552–554

    Google Scholar 

  5. Boyle MJ, Vasak E, Tschunigg M, Turner JJ, Penny SR, Cooper DA, Tindall B, Sewell WA (1993) Subtypes of EpsteinBarr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood 81:468–474

    Google Scholar 

  6. Carbone P, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee of Hodgkin's disease staging classification. Cancer Res 31:1860–1861

    Google Scholar 

  7. Chang KL, Albujar PF, Chen Y-Y, Johnson RM, Weiss LM (1993) High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 81:496–501

    Google Scholar 

  8. Chang KL, Chen Y-Y, Shibata D, Weiss LM (1992) Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1:246–255

    Google Scholar 

  9. Chleq-Deschamps CM, LeBrun DP, Huie P, Besnier DP, Warnke RA, Sibley RK, Cleary ML (1993) Topographical dissociation of bcl-2 messenger RNA and protein expression in human lymphoid tissues. Blood 81:293–298

    Google Scholar 

  10. Cordell J, Falini B, Erber ON, Ghosh AK, Abdulaziz Z, Macdonald S, Polford K, Stein H, Mason DY (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 31:219–229

    Google Scholar 

  11. Dawson CW, Rickinson AB, Young LS (1990) Epstein-Barr virus latent membrane protein inhibits human cell differentation. Nature 344:770–778

    Google Scholar 

  12. DeVita VT jr, Hubbard SM (1993) Hodgkin's disease. New Engl J Med 328:560–565

    Google Scholar 

  13. Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H (1992) Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421–427

    Google Scholar 

  14. Fellbaum C, Hansmann M-L, Niedermeyer H, Kraus I, Alavaikko MJ, Blanco G, Aine R, Busch R, Pütz B, Fischer R, Höfler H (1992) Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease. Am J Clin Pathol 98:319–323

    Google Scholar 

  15. Gerdes J, van Baarlen J, Pileri S, Schwarting R, van Unnik JA, Stein H (1987) Tumour cell growth fraction in Hodgkin's disease. Am J Pathol 128:390–393

    Google Scholar 

  16. Gledhill S, Gallagher A, Jones DB, Krajewski AS, Alexander FE, Klee E, Wright DH, O'Brien C, Onions DE, Jarrett RF (1991) Viral involvement in Hodgkin's disease: detection of type A Epstein-Barr virus genomes in tumour samples. Br J Cancer 64:227–232

    Google Scholar 

  17. Glickman JA, Howe JG, Steitz JA (1988) Structural analyses of EBER-1 and EBER-2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol 62:902–911

    Google Scholar 

  18. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349:612–614

    Google Scholar 

  19. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107–1115

    Google Scholar 

  20. Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Müller-Lantzsch, Stein H (1991) Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 88:4766–4770

    Google Scholar 

  21. Herbst H, Niedobitek G, Kneba M, Hummel M, Finn T, Anagnostopoulos I, Bergholz M, Krieger G, Stein H (1990) High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am J Pathol 137:13–18

    Google Scholar 

  22. Herbst H, Steinbrecher E, Niedobitek G, Young LS, Brooks L, Müller-Lantzsch N, Stein H (1992) Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 80:484–491

    Google Scholar 

  23. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334–336

    Google Scholar 

  24. Hockenbery DM, Zutter M, Hickley W, Nahm N, Korsmeyer SJ (1991) Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961–6965

    Google Scholar 

  25. Howe JG, Steitz JA (1986) Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA 83:9006–9010

    Google Scholar 

  26. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580

    Google Scholar 

  27. Hummel M, Anagnostopoulos I, Dallenbach F, Korbjuhn P, Dimmler C, Stein H (1992) EBV infection in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Hematol 82:689–694

    Google Scholar 

  28. Ishii Y, Takami T, Yuasa H, Takei T, Kikuchi (1984) Two distinct antigen systems in human B-lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies. Clin Exp Immunol 58:183–192

    Google Scholar 

  29. Jarrett RF, Gallagher A, Jones DB, Alexander FE, Krajewski AS, Gledhill S, Wright DH, Cartwright RA, Onions DE (1991) Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol 44:844–848

    Google Scholar 

  30. Joske DJL, Emery-Goodmann A, Bachmann E, Bachmann F, Odermatt E, Knecht H (1992) Epstein-Barr virus burden in Hodgkin's disease is related to latent membrane protein gene expression but not to active viral replication. Blood 80:2610–2613

    Google Scholar 

  31. Kaplan HS (1980) Hodgkin's disease, 2nd edn. Harvard University Press, London

    Google Scholar 

  32. Kieff E, Liebowitz D (1991) Epstein-Barr virus and its replication. In: Fields BN, Knipe DM (eds) Fundamental virology, 2nd edn. Raven, New York, pp 897–928

    Google Scholar 

  33. Knecht H, Odermatt F, Bachmann E, Teixera S, Sahli R, Hayoz D (1991) Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin's disease without genomic evidence of B- or T-cell clonality. Blood 78:760–767

    Google Scholar 

  34. Kondo E, Nakamura S, Ononue H, Matsuo Y, Aoki H, Hayashi K, Takahashi K, Minowada J, Nomura S, Akagi T (1992) Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization. Blood 80:2044–2051

    Google Scholar 

  35. Korsmeyer SJ (1992) Bcl-2 initiates a new category of onco-genes: regulators of cell death. Blood 80:879–886

    Google Scholar 

  36. Kreipe H, Heidebrecht HJ, Hansen S, Röhlk W, Kubbies M, Wacker HH, Tiemann M, Radzun HJ, Parwaresch R (1993) A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissue by the monoclonal antibody Ki-S1. Am J Pathol 142:3–9

    Google Scholar 

  37. Kreipe H, Wacker HH, Heidebrecht HJ, Schröter K, Hauberg M, Tiemann M, Parwaresch R (1993) Determination of the growth fraction in non-Hodgkin's lymphoma by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Am J Pathol 142:1689–1694

    Google Scholar 

  38. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orenteich N, Polk F, Vogelman J (1989) Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 320:689–695

    Google Scholar 

  39. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320–322

    Google Scholar 

  40. Pinkus GS, Said JW (1988) Hodgkins's disease, lymphocyte predominance type, nodular — further evidence for a B-cell derivation. Am J Pathol 133:211–217

    Google Scholar 

  41. Schellong G, Brämswig JH, Hörnig-Franz I (1992) Treatment of children with Hodgkin's disease. Results of the German Pediatric Oncology Group. Ann Oncol 3 [Suppl 4]: 73–76

    Google Scholar 

  42. Schwarting R, Gerdes J, Dürkop H, Falini B, Pilieri S, Stein H (1989) Ber-H2: a new anti-Ki-1 (CD 30) monoclonal antibody directed at a formol-resistant epitope. Blood 74:1678–1689

    Google Scholar 

  43. Stetler-Stevenson M (1992) The t (14; 18) translocation in Hodgkin's disease. J Natl Cancer Inst 84:1770–1771

    Google Scholar 

  44. Straus SE, Fleisher GR (1989) Infectious mononucleosis, epidemiology and pathogenesis. In: Schlossberg D (ed) Infectious mononucleosis, 2nd ed Springer, Berlin Heidelberg New York, pp 8–28

    Google Scholar 

  45. Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes hematopoietic cell survival and cooperates with c-myc to immortalize B-cells. Nature 335:440–442

    Google Scholar 

  46. Vestlev PM, Pallesen G, Sandvej K, Hamilton-Dutoit SJ, Bendtzen SM (1992) Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein. Int J Cancer 50:670–671 (letter)

    Google Scholar 

  47. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831–840

    Google Scholar 

  48. Weiss LM, Chen Y-Y, Liu X-F, Shibata D (1991) EpsteinBarr virus and Hodgkin's disease. Am J Pathol 139:1259–1261

    Google Scholar 

  49. Weiss LM, Movahed LA, Warnke RA, Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320:502–506

    Google Scholar 

  50. Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65:1097–1098

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Kiel, Schwanenweg 20, D-24105, Kiel, Germany

    A. Claviez & R. Schneppenheim

  2. Institute of Hematopathology, University of Kiel, Schwanenweg 20, D-24105, Kiel, Germany

    M. Tiemann & R. Parwaresch

  3. Institute of Pathology, University of Kiel, Schwanenweg 20, D-24105, Kiel, Germany

    J. Peters & H. Kreipe

Authors
  1. A. Claviez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Tiemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Kreipe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Schneppenheim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Parwaresch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Claviez, A., Tiemann, M., Peters, J. et al. The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood. Ann Hematol 68, 61–66 (1994). https://doi.org/10.1007/BF01715132

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01715132

Key words

Search

Navigation